Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-20 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-10 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |